These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1283591)

  • 1. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
    Ruilope LM; Casal MC; Guerrero L; Alcázar JM; Férnandez ML; Lahera V; Rodicio JL
    Drugs; 1992; 44 Suppl 1():94-8. PubMed ID: 1283591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group.
    Redón-Más J; Abellán-Alemán J; Aranda-Lara P; de la Figuera-von Wichmann M; Luque-Otero M; Rodicio-Díaz JL; Ruilope-Urioste LM; Velasco-Quintana J
    J Hypertens; 1993 Jun; 11(6):665-71. PubMed ID: 8397246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antihypertensive effect of verapamil in patients with chronic renal failure.
    Rodicio JL; Alcazar JM; Ruilope LM
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S41-3. PubMed ID: 1289513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.
    Schohn DC; Jahn HA; Maareck M
    Drugs; 1993; 46 Suppl 2():113-9; discussion 119-20. PubMed ID: 7512464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt sensitivity and the blood pressure response to verapamil.
    Weinberger MH; Wagner UL; Fineberg NS
    Am J Hypertens; 1994 Jun; 7(6):515-9. PubMed ID: 7917149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mild to moderate hypertension with verapamil slow-release in outpatients. Collaborative Group of the Spanish League for the Fight Against Hypertension.
    Gómez Pajuelo C; Pérez Naranjo J; Ruiz Martínez I
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S50-2. PubMed ID: 2475687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do changes in dietary salt influence blood pressure of hypertensive patients pharmacologically controlled with verapamil? The Salt-Switching-Study (SSS).
    Redón J; Lozano JV; de la Figuera M; Rodriguez JC; Garrido J; Alés-Martínez JE; Alvarez-Cantalapiedra I; Velasco-Quintana J
    J Hum Hypertens; 1995 Feb; 9(2):143-7. PubMed ID: 7752177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihypertensive effect of verapamil at extremes of dietary sodium intake.
    Nicholson JP; Resnick LM; Laragh JH
    Ann Intern Med; 1987 Sep; 107(3):329-34. PubMed ID: 3619222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil in antihypertensive treatment of patients on renal replacement therapy--clinical implications and pharmacokinetics.
    Beyerlein C; Csaszar G; Hollmann M; Schumacher A
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S35-7. PubMed ID: 2261942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
    Waeber B; Burnier M; Nussberger J; Brunner HR
    J Hypertens Suppl; 1990 Sep; 8(4):S37-41. PubMed ID: 2258782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
    Kirchengast M
    J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
    Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
    Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
    J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Australian National Health and Medical Research Council Dietary Salt Study Management Committee.
    Lancet; 1989 Feb; 1(8635):399-402. PubMed ID: 2563786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in older patients with hypertension.
    Weir MR; Lavin PT
    Clin Ther; 1991; 13(3):401-8. PubMed ID: 1659494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour blood pressure monitoring after a single dose of sustained-release verapamil.
    Cardillo C; Musumeci V; Mores N; Baroni S; Cremona G; Tutinelli F; Folli G
    Cardiovasc Drugs Ther; 1988 Nov; 2(4):533-7. PubMed ID: 3154631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.